Navigation Links
AbbVie To Present Investigational Data From Phase II Hepatitis C Program At The Liver Meeting
Date:10/1/2013

13, AbbVie's investigational DAA regimen with and without ribavirin for HCV genotype 1 was designated as a Breakthrough Therapy by the U.S. Food and Drug Administration (FDA). This designation is intended to help expedite the development of drugs for serious or life-threatening conditions and is based in part on preliminary clinical evidence demonstrating a drug or regimen may have substantial improvement on at least one clinically significant endpoint compared to available therapy.

AbbVie Hepatitis C Data at AASLD 2013

  • Trends in Liver-Related Healthcare Resource Utilization for HCV-Infected Individuals in the US: 2002-2010
    Poster #367
    November 2nd, 2:00PM ET; Poster Hall
    This study analyzed years 2002-2010 of the National Inpatient Sample (NIS) data set of hospital admissions from the Healthcare Cost and Utilization Project (HCUP) to determine the number of adult (age 20+ years) liver-related hospital admissions occurring in HCV-infected patients (identified by ICD-9 codes).
  • Interferon- and Ribavirin-free Regimen of ABT-450/r + ABT-267 in HCV Genotype 1b-infected Treatment-Naïve Patients and Prior Null Responders
    Oral Presentation: Parallel Session 75
    November 3rd, 5:15PM ET; Hall E
    This oral presentation includes data from the phase IIb PEARL-I study, which examines an interferon-free, ribavirin-free investigational regimen of ABT-450/r plus ABT-267 in 82 patients with HCV genotype 1b.
  • Low Relapse Rate Leads to High Concordance of SVR4 and SVR12 with SVR24 After Treatment with ABT-450/r, ABT-267, ABT-333 + Ribavirin in Patients with Chronic HCV Genotype 1 Infection in the AVIATOR Study
    Poster #1089
    November 3rd, 8:00AM ET; Poster Hall
    This study evaluated the concordance of SVR24 with rapid virologic response (RVR), SVR4 and SVR12 in treatment groups from the phase IIb AVIATOR study in 247 patients.
  • High Medication Adherence in HCV-Infected Patients Ta
    '/>"/>

  • SOURCE AbbVie Inc.
    Copyright©2012 PR Newswire.
    All rights reserved

    Page: 1 2 3 4 5 6 7

    Related medicine technology :

    1. AbbVie and Galapagos to Co-Develop Cystic Fibrosis Therapies
    2. Strong Sales and Healthcare Reforms Benefit Earnings - Research Report on Gilead, Pfizer, Merck, AbbVie, and LifePoint
    3. After Reviewing Brief Product Profiles, Surveyed Physicians Believe that Likely Candidates for Late-Phase Chronic Kidney Disease Products from AbbVie, Mitsubishi Tanabe, Eli Lilly, Concert, Fibrogen and Pfizer are Typically Stage 3b and 4 Patients
    4. AbbVie Declares Quarterly Dividend
    5. AbbVie Presents Preliminary Results from Phase I Study of Investigational Oncology Compound ABT-199/GDC-0199 in Patients with High-Risk Chronic Lymphocytic Leukemia (CLL) at European Hematology Association Annual Meeting
    6. For Treating Psoriatic Arthritis, Clinical Data and Thought Leaders Opinions Indicate that AbbVie/Eisais Humira Has the Best Clinical Profile Among Key Marketed Therapies
    7. AbbVie to Participate in 2013 Jeffries Global Healthcare Conference
    8. AbbVie Initiates Phase 3 Study of Its Investigational Compound Atrasentan on Renal Outcomes in Patients with Diabetic Nephropathy
    9. AbbVie and Galapagos Extend GLPG0634 Collaboration to Include Crohns Disease
    10. AbbVie to Present Data on Investigational Anti-Cancer Compounds at American Society of Clinical Oncology Annual Meeting
    11. AbbVie and Alvine to Collaborate on Investigational Oral Therapy for Celiac Disease
    Post Your Comments:
    *Name:
    *Comment:
    *Email:
    (Date:8/31/2015)... 31, 2015   BioLife Solutions , Inc. ... and marketer of proprietary clinical grade cell and ... freeze media and a related cloud ... smart shippers ("BioLife" or the "Company"), ... advanced biopharmaceutical company focused on developing and commercializing ...
    (Date:8/30/2015)... 30, 2015 La solución ... l cuidado al paciente a ... Royal Philips  (NYSE: PHG, AEX: ... IntelliSpace Cardiovascular , un sistema web de gestión de ... analizar y compartir imágenes cardiovasculares e información en cualquier ...
    (Date:8/28/2015)... , Aug. 28, 2015  Delays in the ... can slow down the decision-making process, resulting in ... absolutely critical for biopharmaceutical companies to develop a ... process for quicker and more meaningful insights. ... Practices, LLC, nearly three-quarters of benchmarked study participants ...
    Breaking Medicine Technology:BioLife Solutions Customer TiGenix Phase 3 Clinical Trial Meets Primary Endpoint 2BioLife Solutions Customer TiGenix Phase 3 Clinical Trial Meets Primary Endpoint 3BioLife Solutions Customer TiGenix Phase 3 Clinical Trial Meets Primary Endpoint 4BioLife Solutions Customer TiGenix Phase 3 Clinical Trial Meets Primary Endpoint 5Philips presenta IntelliSpace Cardiovascular en el Congreso ESC 2015 2Philips presenta IntelliSpace Cardiovascular en el Congreso ESC 2015 3Expediting the Pharmaceutical Market Research Process for Faster Insights 2
    ... April 21, 2011 Marinus Pharmaceuticals, Inc., the ... nervous system disorders, today announced commencement of a ... for the treatment of posttraumatic stress disorder (PTSD). ... specific neurosteroid recognition site. Neurosteroid levels have been ...
    ... 21, 2011 Reportlinker.com announces that a new ... Body Contouring Devices - Global ... 2017 http://www.reportlinker.com/p0484508/Body-Contouring-Devices---Global-Pipeline-Analysis-Competitive-Landscape-and-Market-Forecasts-to-2017.html ... Competitive Landscape and Market Forecasts to 2017 ...
    Cached Medicine Technology:Marinus Pharmaceuticals Announces Commencement of Phase 2 Trial of Ganaxolone for the Treatment of Posttraumatic Stress Disorder 2Marinus Pharmaceuticals Announces Commencement of Phase 2 Trial of Ganaxolone for the Treatment of Posttraumatic Stress Disorder 3Reportlinker Adds Body Contouring Devices - Global Pipeline Analysis, Competitive Landscape and Market Forecasts to 2017 2Reportlinker Adds Body Contouring Devices - Global Pipeline Analysis, Competitive Landscape and Market Forecasts to 2017 3Reportlinker Adds Body Contouring Devices - Global Pipeline Analysis, Competitive Landscape and Market Forecasts to 2017 4Reportlinker Adds Body Contouring Devices - Global Pipeline Analysis, Competitive Landscape and Market Forecasts to 2017 5Reportlinker Adds Body Contouring Devices - Global Pipeline Analysis, Competitive Landscape and Market Forecasts to 2017 6Reportlinker Adds Body Contouring Devices - Global Pipeline Analysis, Competitive Landscape and Market Forecasts to 2017 7Reportlinker Adds Body Contouring Devices - Global Pipeline Analysis, Competitive Landscape and Market Forecasts to 2017 8Reportlinker Adds Body Contouring Devices - Global Pipeline Analysis, Competitive Landscape and Market Forecasts to 2017 9Reportlinker Adds Body Contouring Devices - Global Pipeline Analysis, Competitive Landscape and Market Forecasts to 2017 10Reportlinker Adds Body Contouring Devices - Global Pipeline Analysis, Competitive Landscape and Market Forecasts to 2017 11Reportlinker Adds Body Contouring Devices - Global Pipeline Analysis, Competitive Landscape and Market Forecasts to 2017 12
    (Date:8/31/2015)... ... 31, 2015 , ... Wound Care Advantage, a leader in ... to Hyperbaric Medicine Course. The next UHMS approved 40-hour Introduction to Hyperbaric Medicine ... Long Beach, CA. The meeting is open for registration from physicians, clinicians and ...
    (Date:8/31/2015)... Dayton, Ohio (PRWEB) , ... August 31, 2015 ... ... Jenny Michael as Vice President, Marketing and Corporate Communications. In this capacity, Michael ... , CareSource is an industry leader in consumer-focused programs that have contributed ...
    (Date:8/31/2015)... ... August 31, 2015 , ... In an article published August 24th ... Global Open Journal that discusses the future of 3-D printing technology as it relates ... customized implants, prosthetics, and other 3-D printed tools could be used to aid in ...
    (Date:8/31/2015)... ... August 31, 2015 , ... NJ Top Docs Presents, Dr. Michael Betsy! Dr. ... Park Ridge, New Jersey, Dr. Michael Betsy graduated from Don Bosco Prep in 1990 and ... as team captain in both sports in his senior year. He was inducted into ...
    (Date:8/31/2015)... ... , ... According to an article published August 3rd on Healio, ... underwent bariatric surgery “felt significantly better two years after surgery.” The article goes on ... study felt that their “mental health had been normalized” at the point when the ...
    Breaking Medicine News(10 mins):Health News:Registration Opens for Wound Care Advantage’s Second UHMS Approved 40-Hour Introduction to Hyperbaric Medicine Course 2Health News:Registration Opens for Wound Care Advantage’s Second UHMS Approved 40-Hour Introduction to Hyperbaric Medicine Course 3Health News:Registration Opens for Wound Care Advantage’s Second UHMS Approved 40-Hour Introduction to Hyperbaric Medicine Course 4Health News:CareSource Names Vice President, Marketing and Corporate Communications 2Health News:Recent Article on 3-D Printing Highlights the Future of Custom Medical Solutions Using the Technology, says Beverly Hills Physicians 2Health News:Recent Article on 3-D Printing Highlights the Future of Custom Medical Solutions Using the Technology, says Beverly Hills Physicians 3Health News:NJ Top Docs Presents, Dr. Michael Betsy! 2Health News:NJ Top Docs Presents, Dr. Michael Betsy! 3Health News:Article on Adolescent Bariatric Surgery Demonstrates the Powerful Effect of Being in Control, Notes Dr. Michael Feiz 2Health News:Article on Adolescent Bariatric Surgery Demonstrates the Powerful Effect of Being in Control, Notes Dr. Michael Feiz 3
    ... American Pacific,Corporation (Nasdaq: APFC ) today announced that ... on Thursday, February 7, 2008. John R.,Gibson, Chairman and ... to review the financial results and outlook of the,Company., ... 2008 at 1:30 p.m.,PST. To access the call please ...
    ... 1 The Chrysler Foundation and,Kenosha (Wis.) Engine Plant ... its new Aquatics Center., Chrysler,s donation will help ... to the YMCA. The center will have two pools: ... The YMCA will break,ground for the aquatic center later ...
    ... AMES, Iowa An anti-virus drug attacks influenza A by ... for the virus to infect healthy cells, according to a ... , Mei Hong, Iowa States John D. Corbett Professor in ... studying the effects of the antiviral drug amantadine on influenza ...
    ... Chiltern, the global contract research,organization, announced today that ... a leading Phase 1 unit located at Ninewells,Hospital and ... Kingdom,s major teaching hospitals. The purchase of DDS supplements,Chiltern,s ... was founded in 1982 and has completed more than ...
    ... and marital status underpin findings of 17-nation study ... factors for suicidal thoughts, plans and attempts are similar ... study, which used data collected by the World Health ... in 17 nations and found that an overall average ...
    ... succeeded in losing weight in a year-long medically supervised ... increase over that period, say researchers from The Children,s ... is a critical period for bone health in later ... the journal Obesity studied 62 adolescents between the ages ...
    Cached Medicine News:Health News:American Pacific to Release Financial Results and Hold Fiscal 2008 First Quarter Investor Teleconference 2Health News:The Chrysler Foundation and Kenosha Engine Plant Donate $100,000 to New YMCA Aquatics Center 2Health News:Iowa State chemists track how drug changes, blocks flu virus 2Health News:Chiltern Announced Today That it has Acquired the Business of Drug Development Solutions (DDS) 2Health News:Chiltern Announced Today That it has Acquired the Business of Drug Development Solutions (DDS) 3Health News:Key Risk Factors for Suicide Consistent Across Globe 2Health News:Bone mineral content continues to increase in obese adolescents during weight loss 2
    The Natural Selection family of specialty allografts is spinal concepts response to surgeon requests for spinal allograft devices to eliminate the need for painful autograft harvesting....
    Transcranial vascular DWL doppler....
    Transcranial vascular DWL doppler....
    ... Neurocare is a full-featured physiologic testing system offered ... contains many of the features of our flagship ... economical price. , ,The smaller size of the ... environment, the physician's office, a mobile service or ...
    Medicine Products: